Mode
Text Size
Log in / Sign up

Novel embolization techniques show promise for Type II endoleaks after EVARNew Embolization Techniques Show Promise for Type II Endoleaks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider novel embolization techniques for T2ELs as promising but limited evidence; larger studies needed.

This narrative review summarizes emerging embolization techniques for managing Type II endoleaks (T2ELs) after endovascular aneurysm repair (EVAR). The authors focus on transcaval embolization (TCE), laser-assisted transgraft embolization (LATE), and shape memory polymer (SMP) embolization, comparing them with conventional embolization methods.

For TCE and LATE, the review describes encouraging early technical and clinical outcomes, though specific effect sizes and absolute numbers are not reported. For SMP embolization, the authors note significant sac shrinkage in more than 85% of patients and prevention of clinically significant T2ELs. These findings are presented qualitatively, without pooled analyses or statistical detail.

The review acknowledges that the evidence remains limited. Larger studies are needed to confirm long-term outcomes and define optimal use of these techniques. Safety data, including adverse events and tolerability, are not reported. No information on funding or conflicts of interest is provided.

In practice, TCE, LATE, and prophylactic SMP embolization are described as promising alternatives to conventional methods, offering high technical success and the potential to reduce reinterventions. However, clinicians should interpret these findings cautiously given the limited and early nature of the evidence.

A new review looked at three newer ways to treat Type II endoleaks, a complication that can happen after endovascular aneurysm repair (EVAR). The techniques are transcaval embolization (TCE), laser-assisted transgraft embolization (LATE), and shape memory polymer (SMP) embolization. The review included observational studies, but the number of patients and follow-up time were not reported.

The review found that TCE and LATE had encouraging early technical and clinical outcomes. For SMP embolization, the review reported significant sac shrinkage in more than 85% of patients and that it prevented clinically significant Type II endoleaks. However, the review did not provide details on safety, such as adverse events or side effects.

The main limitation is that the evidence remains limited. Larger studies are needed to confirm long-term outcomes and to define the best use of these techniques. The review suggests these methods are promising alternatives to conventional embolization, with high technical success and the potential to reduce reinterventions.

For patients, this means there are new options being explored for Type II endoleaks, but more research is needed before they become standard. Anyone with a Type II endoleak should discuss treatment options with their doctor.

What this means for you:
Newer embolization techniques for Type II endoleaks show early promise, but more research is needed.

Common questions

What are the new techniques for Type II endoleaks?

The review looked at transcaval embolization (TCE), laser-assisted transgraft embolization (LATE), and shape memory polymer (SMP) embolization. These are alternatives to conventional embolization methods for treating Type II endoleaks after endovascular aneurysm repair (EVAR).

How well do these new techniques work?

TCE and LATE showed encouraging early technical and clinical outcomes. SMP embolization led to significant sac shrinkage in more than 85% of patients and prevented clinically significant Type II endoleaks. However, the review did not provide detailed numbers or long-term follow-up.

Are these new techniques safe?

The review did not report safety information such as adverse events or side effects. Because the evidence is limited, more studies are needed to fully understand the safety of these techniques. Talk to your doctor about the risks and benefits.

Who might benefit from these new techniques?

These techniques are being studied for patients with Type II endoleaks after EVAR. The review suggests they are promising alternatives to conventional methods, but larger studies are needed to confirm long-term outcomes and define the best use.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BackgroundType II endoleaks (T2ELs) are a frequent complication after endovascular aneurysm repair (EVAR), posing a risk of aneurysm expansion. This review evaluates modern techniques for T2ELs management, moving beyond traditional embolization methods.MethodsRecent controlled trials and observational studies were analyzed to trace evidence on conventional and novel techniques employed in managing T2ELs.ResultsNovel techniques, such as transcaval embolization (TCE) and laser-assisted transgraft embolization (LATE), have demonstrated encouraging early technical and clinical outcomes, although the available evidence remains limited. In addition, shape memory polymer (SMP) embolization resulted in significant sac shrinkage in >85% of patients and prevented clinically significant T2ELs.ConclusionsTCE, LATE, and prophylactic SMP embolization are promising alternatives to conventional methods, offering high technical success and the potential to reduce reinterventions. Larger studies are needed to confirm long-term outcomes and define optimal use.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.